• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

GlaxoSmithKline

Posted inIn the Pipeline, Infections, New Drugs, Regulatory

Shingrix: Excellent Vaccine Against Shingles

by Julia Mardi and Timur Burkhanayev April 22, 2024April 22, 2024

Shingrix for robust and long-lasting prevention of herpes zoster and postherpetic neuralgia in all adults.

Posted inInfections, New Drugs, Regulatory

mResvia, Arexvy, Abrysvo: Top Quality RSV Vaccines

by Nik Resovski and Timur Burkhanayev April 19, 2024April 19, 2024

It’s time to bury respiratory syncytial virus in the abyss of immunization fire.

Posted inClinical Trials, Infections

Bepirovirsen: New Drug for Hepatitis B

by Tanya von Reuss November 11, 2022November 11, 2022

Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.

coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

by Tanya von Reuss and Timur Burkhanayev August 31, 2022September 8, 2022

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

multiple-myeloma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Tecvayli: New Drug for Multiple Myeloma

by Mark Gubar August 24, 2022September 8, 2022

Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

by Mark Gubar June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine

by Nik Resovski June 5, 2022April 11, 2024

Innovative Medicago’s vaccine is made by molecular pharming technology.

Posts pagination

1 2 3 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2026 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×